Leg Ulcer Treatments Global Market Report 2026

Leg ulcer treatments encompass a variety of medical therapies, clinical procedures, and wound-care products used to treat and heal persistent wounds on the lower extremities, commonly resulting from venous disorders, arterial conditions, diabetes, or pressure-related injuries. These treatment approaches are aimed at accelerating wound recovery, minimizing the risk of infection, relieving discomfort, and enhancing blood circulation through medical care, advanced dressings, compression techniques, and specialized wound-management solutions.

The primary ulcer types of leg ulcer treatments include venous leg ulcers, arterial leg ulcers, diabetic leg ulcers, pressure ulcers, and other ulcer types. Venous leg ulcers refer to chronic wounds that develop due to impaired venous circulation, typically occurring on the lower limbs. These conditions are managed through treatment types including advanced wound care therapy, traditional wound care, surgical treatment, and adjunctive therapy, and they are utilized by end users such as hospitals and clinics, homecare settings, ambulatory surgical centers, and others.

Tariffs are influencing the leg ulcer treatments market by increasing the cost of imported advanced wound care products, compression systems, surgical instruments, and biologic-based therapies used in chronic wound management. This is increasing overall treatment expenditures and slowing procurement processes for hospitals and clinics, particularly in import-dependent regions such as Asia-Pacific and Latin America. Hardware-linked segments such as advanced dressings, wound monitoring devices, and surgical support systems are most affected due to strong reliance on global supply chains. However, tariffs are also fostering local manufacturing initiatives, strengthening regional supplier ecosystems, and accelerating investments in domestic wound care production capabilities, which may enhance long-term affordability and supply resilience.

The leg ulcer treatments market size has grown strongly in recent years. It will grow from $4.05 billion in 2025 to $4.36 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of diabetes, increasing cases of peripheral vascular disease, limited access to advanced wound care solutions, growing hospital admissions for chronic wound conditions, and low awareness regarding early-stage ulcer treatment and management.

The leg ulcer treatments market size is expected to see strong growth in the next few years. It will grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to the increasing burden of the aging population, rising demand for outpatient-based wound care services, growing emphasis on preventive vascular screening programs, expansion of home-based wound management practices, and continuous improvement in clinical guidelines for chronic ulcer treatment. Major trends include rising prevalence of chronic venous and diabetic ulcers, increasing incidence of impaired wound healing among elderly populations, growing diabetes-related complications leading to leg ulcers, a shift toward standardized evidence-based wound care protocols, and increasing adoption of compression therapy and debridement-based treatment approaches.

The increasing prevalence of chronic wounds is anticipated to drive the growth of the leg ulcer treatments market going forward. Chronic wounds are injuries that do not heal within the expected period, typically remaining open for more than three months. The prevalence of chronic wounds is increasing due to an aging population, as older adults are more prone to conditions that delay healing, such as diabetes, poor blood circulation, and weakened skin integrity. Leg ulcer treatments assist in managing chronic wounds by enhancing blood circulation, preventing and controlling infections, reducing inflammation, and supporting tissue regeneration through compression therapy, specialized wound dressings, and targeted medical care, which collectively promote consistent and effective healing. For instance, in November 2023, according to the National Health Service (NHS) England, a UK-based government department, between 01/10/2022 and 01/10/2023, a total of 193 inpatients were reported to have developed bed sores, pressure sores, or pressure ulcers during their hospital stay. Therefore, the increasing prevalence of chronic wounds is driving the growth of the leg ulcer treatments market.

Leading companies operating in the leg ulcer treatments market are focusing on developing innovative products, such as portable negative pressure wound therapy (NPWT) systems to improve healing outcomes, enhance patient mobility, and reduce long-term treatment costs associated with chronic venous and diabetic leg ulcers. NPWT systems are advanced wound-care devices that apply controlled, localized sub-atmospheric pressure to the wound bed using a sealed dressing connected to a compact pump and drainage canister. for example, in April 2024, Smith+Nephew plc, a UK-based medical technology company, launched the RENASYS EDGE Negative Pressure Wound Therapy System, an innovative home-care-focused device designed to support patients living with chronic wounds, including leg ulcers. The system is lightweight and compact, allowing it to be easily carried or worn by patients, and features a discreet canister that minimizes visibility while maintaining effective exudate management. It operates quietly to avoid disrupting daily activities, improving patient compliance and quality of life during long-term treatment. The device is widely used for managing chronic venous leg ulcers, diabetic foot ulcers, and other complex wounds, offering improved mobility, comfort, and healing efficiency compared to conventional dressing-based approaches.

In August 2023, Coloplast A/S, a Denmark-based healthcare company, acquired Kerecis for an undisclosed amount. Through this transaction, Coloplast A/S sought to reinforce its leadership in advanced wound care by integrating fish-skin-derived biologic graft technology into its existing portfolio, thereby enhancing its regenerative medicine and tissue repair offerings across chronic wound and surgical care applications. Kerecis is an Iceland-based medical device and biologics company focused on developing fish-skin graft products utilized for wound healing, tissue regeneration, and soft tissue repair in both chronic and acute wound settings.

Major companies operating in the leg ulcer treatments market are Cardinal Health Inc., Essity AB, Solventum Corporation, B. Braun Melsungen AG, Smith & Nephew plc, ConvaTec Group Plc, Molnlycke Health Care AB, Coloplast A/S, Paul Hartmann AG, Winner Medical Co. Ltd., Integra LifeSciences Holdings Corporation, Lohmann & Rauscher International GmbH & Co. KG, Urgo Medical SAS, Organogenesis Holdings Inc., MiMedX Group Inc., DeRoyal Industries Inc., Advancis Medical Limited, MediWound Ltd., Triage Meditech Pvt. Ltd., Natrox Wound Care Ltd.

North America was the dominant region in the leg ulcer treatments market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in leg ulcer treatments report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the leg ulcer treatments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leg ulcer treatments market consists of revenues earned by entities by providing services such as wound assessment, debridement procedures, compression therapy application, infection management, outpatient wound care services, home-based wound management, and chronic wound monitoring and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The leg ulcer treatments market also includes sales of advanced wound dressings, compression bandages, wound care devices, negative pressure wound therapy systems, topical treatment products, and related medical supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The leg ulcer treatments market research report is one of a series of new reports from The Business Research Company that provides leg ulcer treatments market statistics, including leg ulcer treatments industry global market size, regional shares, competitors with a leg ulcer treatments market share, detailed leg ulcer treatments market segments, market trends and opportunities, and any further data you may need to thrive in the leg ulcer treatments industry. This leg ulcer treatments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Leg Ulcer Treatments Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses leg ulcer treatments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leg ulcer treatments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leg ulcer treatments market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Ulcer Type: Venous Leg Ulcers; Arterial Leg Ulcers; Diabetic Leg Ulcers; Pressure Ulcers; Other Ulcer Types
• 2) By Treatment Type: Advanced Wound Care Therapy; Traditional Wound Care; Surgical Treatment; Adjunctive Therapy
• 3) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Venous Leg Ulcers: Active Venous Leg Ulcers; Recurrent Venous Leg Ulcers; Chronic Venous Leg Ulcers; Infected Venous Leg Ulcers; Non Infected Venous Leg Ulcers
• 2) By Arterial Leg Ulcers: Ischemic Arterial Ulcers; Necrotic Arterial Ulcers; Painful Arterial Ulcers; Non Healing Arterial Ulcers; Mixed Arterial Ulcers
• 3) By Diabetic Leg Ulcers: Neuropathic Diabetic Ulcers; Ischemic Diabetic Ulcers; Neuro Ischemic Diabetic Ulcers; Infected Diabetic Ulcers; Non Infected Diabetic Ulcers
• 4) By Pressure Ulcers: Stage One Pressure Ulcers; Stage Two Pressure Ulcers; Stage Three Pressure Ulcers; Stage Four Pressure Ulcers; Unstageable Pressure Ulcers
• 5) By Other Ulcer Types: Traumatic Ulcers; Vasculitic Ulcers; Malignant Ulcers; Infectious Ulcers; Mixed Etiology Ulcers
• Companies Mentioned: Cardinal Health Inc.; Essity AB; Solventum Corporation; B. Braun Melsungen AG; Smith & Nephew plc; ConvaTec Group Plc; Molnlycke Health Care AB; Coloplast A/S; Paul Hartmann AG; Winner Medical Co. Ltd.; Integra LifeSciences Holdings Corporation; Lohmann & Rauscher International GmbH & Co. KG; Urgo Medical SAS; Organogenesis Holdings Inc.; MiMedX Group Inc.; DeRoyal Industries Inc.; Advancis Medical Limited; MediWound Ltd.; Triage Meditech Pvt. Ltd.; Natrox Wound Care Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.